CardiacWire

DECEMBER 6, 2024

Topline results from the SURMOUNT-5 trial found Eli Lillys tirzepatide led to far greater weight loss than Novo Nordisks semaglutide, giving Lilly a boost in the race to become Americas go-to GLP-1. Semaglutide and tirzepatide both originally received FDA approval for treating adults with T2D, with those approvals later extending to weight loss management.

Obesity 90

Obesity Hypertension 90

Medical Xpress - Cardiology

DECEMBER 6, 2024

New research from Wake Forest University School of Medicine suggests that living in a disadvantaged neighborhood is associated with higher blood pressure and lower cognitive scores, even among people who do not have an existing diagnosis of mild cognitive impairment.

Blood Pressure 111

Blood Pressure Research 111

HCPLive

DECEMBER 6, 2024

In this analysis, investigators determined that the eliciting dose of an allergen may be an unpredictable marker for the severity of an allergic reaction.

59

59

Medical Xpress - Cardiology

DECEMBER 6, 2024

There is a U-shaped association between alcohol consumption and coronary heart disease (CHD) and type 2 diabetes (T2D) but no evidence for a causal association, according to a study published online Nov. 24 in Alcohol: Clinical and Experimental Research.

Heart Disease 105

Heart Disease Diabetes Research 105

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Patient Care

HCPLive

DECEMBER 6, 2024

Topline results from APPULSE-PNH show the positive efficacy and safety of twice-daily oral iptacopan in adults with PNH switched from anti-C5 therapies.

59

59

Medical Xpress - Cardiology

DECEMBER 6, 2024

Stroke survivors have an 80% increased risk of dementia compared to people who've never suffered a stroke, a new study finds.

Dementia 97

Dementia Stroke Strokes Research 97

Medical Xpress - Cardiology

DECEMBER 6, 2024

Severe hemophilia A is a genetic disorder that prevents blood from clotting properly, posing a constant risk of dangerous bleeding episodes. Infants with severe hemophilia A (HA) are at risk of brain bleeds, which can lead to serious long-term brain damage. Emicizumab (Hemlibra) was approved by the FDA in 2018 to prevent and reduce bleeding for patients who suffer from hemophilia A.

83

83

HCPLive

DECEMBER 6, 2024

Schattenberg reviews results from a posthoc analysis of the ENLIVEN study suggesting pegozafermins impact on preventing progression to cirrhosis.

59

59

Medical Xpress - Cardiology

DECEMBER 6, 2024

Noninferiority of reduced- versus full-dose anticoagulants cannot be proven in patients with venous thromboembolism who need extended anticoagulation, according to a study to be presented at the annual meeting of the American Society of Hematology, held from Dec. 7 to 10 in San Diego.

52

52

HCPLive

DECEMBER 6, 2024

The rheumatology month in review emphasizes new data from ACR 2024 in lupus, gout, and fibromyalgia.

52

52

American College of Cardiology

DECEMBER 6, 2024

"Courtside with the Chair" is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology.

Pediatrics 49

Pediatrics Exercise Article 49

HCPLive

DECEMBER 6, 2024

The biosimilars month in review highlights new equivalency data for denosumab and tocilizumab biosimilars.

52

52

Circulation: Heart Failure

DECEMBER 6, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:In heart failure, sympathetic excess and exercise intolerance impair quality of life. In heart failure with reduced ejection fraction, exercise stimulates a reflex increase in muscle sympathetic nerve activity (MSNA) that relates inversely to peak oxygen uptake (VO2peak). Whether similar sympathoexcitatory responses are present in heart failure with preserved EF (HFpEF) and relate to VO2peakare unknown.METHODS:In 13 patients with HFpEF (706

Preserved Ejection Fraction 40

Preserved Ejection Fraction Exercise Heart Failure Quality of Life 40

HCPLive

DECEMBER 6, 2024

This Month in Review captures November updates in the psychiatry pipeline.

52

52

American College of Cardiology

DECEMBER 6, 2024

The following are key points to remember from an American Heart Association scientific statement on the long-term management of right ventricular outflow tract (RVOT) dysfunction in repaired tetralogy of Fallot (TOF).

Article 40

Article 40

HCPLive

DECEMBER 6, 2024

Andreas Kremer, MD, PhD, MHBA, describes the burden of pruritus in PBC and the toll it can take on patients quality of life.

Quality of Life 52

Quality of Life 52

American College of Cardiology

DECEMBER 6, 2024

The U.S. Food and Drug Administration's (FDA's) Center for Devices and Radiological Health (CDRH) announced the addition of empty intravenous (IV) containers to the agency's Medical Device Shortages List on Dec. 4.

Article 40

Article 40

HCPLive

DECEMBER 6, 2024

Andreas Kremer, MD, PhD, MHBA, explains shortcomings of traditional PBC therapies for addressing pruritus and what advantages newer agents may offer.

52

52

Dr. Smith's ECG Blog

DECEMBER 6, 2024

A 50-something man presented with worsening severe exertional chest pain which was just resolving as he had an ECG recorded in triage. Time zero. Are the T-waves in leads I and II hyperacute? Hard to tell. How can we know? By the evolution of the ECG! Watch what happends as the heart recovers from its episode of ischemia. The T-waves deflate, demonstrating that the first one was indeed hyperacute. 2 hours T-waves in lead II are significant smaller In lead I not much difference Troponins returned

Coronary Artery Bypass Graft 107

Coronary Artery Bypass Graft Ischemia Chest Pain Stenosis 107

HCPLive

DECEMBER 6, 2024

Andreas Kremer, MD, PhD, MHBA, reviews emerging therapies in PBC, focusing specifically on seladelpar and its impact on pruritus.

52

52

GEMMS

DECEMBER 6, 2024

The holiday season often brings a quieter period for cardiology practices, with fewer patient appointments and a less hectic schedule. This downtime offers the perfect opportunity to focus on internal improvements, such as upgrading your cardiology EHR system. Staying up-to-date with your EHR technology is crucial for providing top-notch patient care, streamlining workflows, and maintaining a competitive edge in the fast-evolving healthcare industry.

Technology 52

Technology Patient Care Outcomes Innovation 52

HCPLive

DECEMBER 6, 2024

Andreas Kremer, MD, PhD, MHBA, explains seladelpars impact on pruritus in PBC based on findings from a posthoc analysis of the RESPONSE trial.

52

52

Frontiers in Cardiovascular Medicine

DECEMBER 6, 2024

PurposeEvaluate the feasibility of quantification of Relaxation Along a Fictitious Field in the 2nd rotating frame (RAFF2) relaxation times in the human myocardium at 3T.MethodsTRAFF2 mapping was performed using a breath-held ECG-gated acquisition of five images: one without preparation, three preceded by RAFF2 trains of varying duration, and one preceded by a saturation prepulse.

Myocardial Infarction 40

Myocardial Infarction Cardiovascular Disease Research 40

HCPLive

DECEMBER 6, 2024

Panelists discuss how patient education and shared decision-making are crucial in selecting appropriate therapies, as they empower patients to understand their treatment options and actively participate in their care.

Education 52

Education 52

HCPLive

DECEMBER 6, 2024

Panelists discuss how Bruton tyrosine kinase (BTK) inhibitors are reshaping the evolving treatment landscape for chronic spontaneous urticaria (CSU) by providing targeted therapeutic options that address underlying mast cell activation.

52

52